What does CUSIP 35655L107 represent in this 13F holders report?

CUSIP 35655L107 is the security identifier for FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS used to aggregate holder disclosures.

How many institutions held FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in Q2 2023?

1 institutional investor reported FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS for Q2 2023. Use the holders table for investor-level position and value details.

FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / SPONSORED ADS
Total 13F shares: 1,466,508
Share change: -35,357,850
Total reported value: $3,783,591
Price per share: $2.58
Number of holders: 1
Value change: -$59,742,505
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 35655L107:

Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q2 2023

As of 30 Jun 2023, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 1,466,508 shares. The largest 1 holders included Syncona Portfolio Ltd. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.